Status:
COMPLETED
Characteristics and Prognosis of Patients With Critical Ischemia at High Risk of Amputation Managed by Endovascular Bypass: a Retrospective Study of 15 Patients
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Limb Ischemia
Eligibility:
All Genders
18+ years
Brief Summary
Obliterative arterial disease of the lower limbs (AOMI) is associated with a high risk of cardiovascular events, with a linear relationship between a fall in the systolic pressure index and a risk of ...
Eligibility Criteria
Inclusion
- Patient whose age ≥ 18 years
- Patient with critical ischemia at high risk of amputation without the option of "traditional" surgical or endovascular revascularization after multidisciplinary staff discussion
- Patient treated by the non-surgical technique called "endovascular bypass"
- Patient with preserved autonomy
Exclusion
- Patient presenting a loss of autonomy, genu flessum analgesic
- Patient with a contraindication to antithrombotic therapy
- Patient with infectious complications of life-threatening ischemic wounds
- Patient under tutorship or curatorship
- Patient deprived of liberty
- Patient opposing the use of his data for this research
Key Trial Info
Start Date :
May 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04066387
Start Date
May 15 2019
End Date
September 1 2019
Last Update
October 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014